"Never doubt that a small group of thoughtful, committed citizens can change the world. Indeed, it is the only thing that ever has."
Cureus is on a mission to change the long-standing paradigm of medical publishing, where submitting research can be costly, complex and time-consuming.
infant, immunocompetent children, case report, septic arthritis, salmonella
Maria Tirta , Dimitris Ampelas, Panagiotis Tsintavis, Anastasia Pilichou, Panayotis Krallis
Cite this article as: Tirta M, Ampelas D, Tsintavis P, et al. (August 05, 2022) Salmonella Septic Hip Arthritis in Immunocompetent Children: Three Case Reports and Literature Review. Cureus 14(8): e27701. doi:10.7759/cureus.27701
Septic arthritis is an orthopaedic emergency, especially considering the pediatric population. Salmonella is a less common aetiologic factor for septic arthritis compared with other Gram-negative bacteria. Its isolation in immunocompetent children and infants is quite rare, with an estimated incidence of 0.1% to 0.2% of septic arthritis cases among children.
We report three rare cases of hip septic arthritis with Salmonella as a confirmed pathogen in immunocompetent children, with two of them being infants. The main symptoms that occurred in all three cases were fever, hip pain/no bearing, and diarrhoea, as well as elevated levels of WBC, C-reactive protein and ESR. The duration of their hospitalization was 20, 26 and 52 days. One case was treated only with antibiotics, while the other two with surgical drainage with/without arthrotomy. All cases had a follow-up of at least one year, with only one of the infants having the femoral head in a subluxated position and early signs of osteonecrosis. Fluoroscopy-assisted closed reduction had to be performed and maintained by hip spica. A new femoral epiphysis was formed at the time of the last follow-up 2.5 years later.
Our case series highlights the possibility of Salmonella typhi septic hip arthritis in immunocompetent individuals. Therefore, Salmonella species must always be kept in mind during the differential diagnosis of septic arthritis in a clinically relevant setting.
Septic arthritis is an important musculoskeletal infection in children and a true orthopaedic emergency [1]. Any delay in diagnosis and treatment may result in irreversible damage to the joint. The knee and hip are the most commonly affected sites followed by the shoulder and other joints [2]. Before the widespread use of vaccination against Haemophilus Influenza type B, the latter was considered the main cause of septic arthritis [3]. Nowadays, Staphylococcus aureus and Streptococci A are responsible for the majority of the confirmed cases [4]. Salmonella sub-species are often isolated in elderly patients, immunocompromised patients, or patients with some sort of haemoglobinopathy [5,6]. Septic arthritis due to Salmonella species in immunocompetent children is a rare entity [7]. In this report, we present three rare cases of Salmonella septic arthritis of the hip in otherwise healthy children. This report has been prepared according to the SCARE guidelines [8].
A 10-year-old boy presented at our hospital's emergency department with symptoms of septic arthritis of the left hip. The patient had a five-day history of vomiting and diarrhoea, abdominal pain, fever (up to 39 oC) and a gradual inability to bear weight on his left side. The patient had no risk factors and no previous history of severe illness. There was no history or evidence of trauma in the affected limb. At the time of the orthopaedic examination, the left hip was in 30o flexion, slight abduction, and external rotation. Blood tests showed leukocytosis (WBC 10.54 x103/μL) and a raised C-reactive protein (CRP 114mg/L). There was no sign of concurrent infection in other sites of the body.
Joint aspiration, drainage and washout were performed, and the patient received empirical treatment with I.V. Ceftriaxone and Amikacin for 10 days. Direct microscopic examination and Gram stain of the synovial fluid revealed the presence of Gram-negative bacteria. Synovial fluid culture developed Salmonella group A (paratyphi) susceptible to Ceftriaxone and Cefixime. The family of the patient was investigated via coproculture, but no Salmonella spp was discovered. Following surgical drainage, the patient’s symptoms improved dramatically. Based on the sensitivity results Amikacin was discontinued and Ceftriaxone was continued as monotherapy for a total of 15 days. On discharge, the CRP had declined to 1.36mg/L and the patient was prescribed orally Cefixime for another four weeks, to complete a six-week course, and started to bear weight after two weeks from the discharge with the use of crutches for 10 days. One year later, during the last follow-up visit, the affected joint was totally functional (flexion 120o, hyperextension 10o, abduction 45o, internal and external rotation 45o) and there was no sign of avascular necrosis of the femoral head.
A nine-month-old girl was transferred to our department from a regional hospital with persistent septic arthritis of the left hip that did not respond to intravenous antibiotic treatment. The patient had a history of minor episodes of diarrhoea about a month before the onset of arthritis, but no signs or symptoms of systemic disease. She had no significant medical illness since birth, birth age of 38 weeks, no complications during pregnancy or labour and her mother was healthy without known immunodeficiency. At the regional hospital, they performed an urgent arthrotomy and surgical drainage. Postoperatively the patient was given I.V. ceftriaxone and her leg was kept in traction. Synovial fluid and blood cultures indicated a Ceftriaxone-sensitive Salmonella enteritidis as the main culprit. The inflammatory markers were still raised after a month of antibiotic treatment (ERS 65mm/hr, CRP 31mg/L) requiring a second surgical debridement.
Imaging with plain x-rays was performed in our department and showed that the head of the left femur was in a subluxated position (Figure 1), while MRI showed early signs of osteonecrosis of the femoral head. Fluoroscopy-assisted closed reduction had to be performed and maintained by hip spica. Ceftriaxone IV treatment continued until the closed reduction, after which Ciprofloxacin was added to the treatment, and after a three-week course of IV antibiotics, the patient was discharged having negative inflammation markers. Two months later hip spica was removed. There was no sign of inflammation and serological markers were within normal values, but the epiphysis of the femoral head had vanished due to the ongoing osteonecrosis (Figure 2). In the follow-up visits, the patient showed significant remodelling potential on par with her young age and was able to bear weight and started walking six months later. A new femoral epiphysis had been formed at the time of her last follow-up 2.5 years later (Figure 3) and the affected joint was totally functional (flexion 115o, hyperextension 10o, abduction 45o, internal and external rotation 45o).
The yellow arrow shows the subluxation of the left femoral head. Fluoroscopy-assisted closed reduction was performed and maintained with a hip spica cast.
The yellow arrow shows that the epiphysis of the femoral head had vanished due to the ongoing osteonecrosis.
The yellow arrow the remodeling of the femoral head after two years. The patient has no symptoms and is able to bear weight.
A nine-month-old boy was transferred to our department from a regional hospital with the diagnosis of salmonellosis based on blood and faecal culture results. The boy's past medical history was free from any systemic or autoimmune disease, had no significant medical illness since birth, birth age of 40 weeks, no complications during pregnancy or labour and his mother was healthy without known immunodeficiency. The initial symptoms - a month before the child’s admission to hospital - were multiple episodes of diarrhoea (6-8/day) which resolved one week later without treatment. The boy was free of symptoms for about a week before the onset of prolonged fever for five days. In addition, the child couldn’t bear weight on his left side when raised on a standing position and had his left hip held in abduction and external rotation when laid down and was admitted to the regional hospital. Upon admission, the blood tests revealed leukocytosis (13.66 x 103/μL) and high inflammatory markers (ESR 75mm/hr, CRP 51mg/L) and clinical examination showed limited range of motion (ROM) on his left hip. Cefotaxime, Clindamycin, and Ampicillin I.V. were administered, and the initial x-ray evaluation was normal. Blood and faecal cultures identified Salmonella enteritidis as the cause of infection and the antibiotic regimen was modified accordingly. Nevertheless, despite the intravenous administration, the episodes of fever and diarrhoea as well as the limited ROM of the left hip persisted for one more week. An MRI of the pelvis and a three-phase bone scan revealed signs of infection of the left hip, while an ultrasound of the hip, which was performed a week later, highlighted the presence of fluid in the articular bursa.
It was decided that the boy should be transferred to a tertiary centre, where the antibiotic regimen was modified to exclude Ampicillin. The inflammatory markers remained high (CRP 30.2mg/L, ESR 125mm/hr). During the next days, the range of ROM of the left hip gradually improved and a week later decrease in the inflammation markers was shown (CRP 3.03mg/L, ESR 80mm/hr). One week later, on discharge, the boy had gained full ROM of his left hip, with a further decrease of the inflammatory markers (CRP 1.71mg/L, ESR 50mm/hr) and no episodes of fever. During the follow-up visits (six months, one year and two years), the boy’s hip was fully functional (flexion 120o, hyperextension 10o, abduction 45o, internal and external rotation 45o) and the x-rays revealed no signs of osteonecrosis on the femoral head.
Table 1 summarizes the main characteristics of the three cases. Table 2 presents the culture reports of the three patients showing organisms isolated, antibiotic sensitivities, inflammatory markers and treatment.
Range of inflammatory markers' normal values for our hospital's lab: WBC - 3.6-9.5x103/μL, CRP - 1-10mg/L, ESR - 3-13mm/hr
Septic arthritis caused by Salmonella is very rare and occurs in approximately 1% of all cases [9], while an early diagnosis of septic arthritis in children is very important because delayed or inadequate treatment carries a risk of permanent disability. Its presence in immunodeficient children or children suffering from an underlying chronic disease is well documented in the literature [10-12]. However, septic arthritis of the hip in otherwise healthy children is infrequent and very few cases have been reported so far.
We performed a literature review to identify all the cases of septic arthritis caused by Salmonella in previously healthy children. PubMed was searched using the search terms “typhoid” or “Salmonella” and “septic arthritis” or “joint infection”, restricting our search to include only those reports of cases in immunocompetent children, up to 16 years of age within the last 20 years, written in the English language. Nine publications were identified, with a total of 13 cases, the details of which are shown in Table 3 [9,13-20]. The age range was from nine months to 16 years old. The hip was the affected joint in most cases, with two cases of shoulder and one knee. Management was typically with a combination of surgical drainage by arthrotomy and prolonged antibiotics. Balakumar et al. highlight that it is difficult to clinically differentiate Salmonella septic arthritis from other usual pathogens as we have to rely on the culture reports, but those who fail to respond to standard antibiotics for the common pathogens should be investigated for other unusual ones [18], as happened in our cases.
A, ampicillin; Am, Amoxycillin; Amk, amikacin; AmoCl, Amoxicillin clavulanic acid; C, chloramphenicol; Cef, cefixime; Cro, ceftriaxone; Cz, Ceftazidime; Cfo, Cefotaxime; Ci, Clindamycin; Cip, ciprofloxacin; Cipi, intermediate susceptibility to ciprofloxacin; Co, Cotrimaxazole; Cu, Cefuraxime; Ge, Gentamycin; Me, Meropenem; Na, nalidixic acid; Ofl, ofloxacin; Su, sulphamethoxazole; Te, Tetracycline; Tm, trimethoprim; IV, intravenous; PO, oral; yr, years; mo, months; wks, weeks.
Our report is the only one that describes the treatment of an infant with early signs of osteonecrosis of the femoral head due to Salmonella septic arthritis. It is of great importance that in neonates and infants septic arthritis is characterized by atypical clinical picture, often causing delayed diagnosis, and in the initial phases of the disease ultrasonographic findings are of greater use compared to radiological imaging, due to relatively late appearance of radiological signs of disease. With the current case report, we highlight that among infants' joint effusion can result in the dislocation of the hip joint and may lead to instability requiring hip spica casting.
Also, we have the longest follow-up in all the three cases (1, 2.5 and 2 years, respectively) compared to the other reports. This is another strength of our study, since the complications may develop slowly, and a long follow-up of one to two years may be required to detect all possible sequelae, especially concerning infants.
This study is not without limitations. Being a retrospective study, it has the inherent limitations of such studies and inference needs to be drawn with caution.
Septic arthritis due to Salmonella is a rarity but still a reality at a young age, even for immunocompetent individuals. It can be resistant to treatment with long-term sequelae for the patient. Immediate surgical drainage providing synovial fluid cultures is the cornerstone for both diagnosis and treatment. The importance of appropriate antibiotic therapy and a long follow-up cannot be overstated.
Orthopaedics and Traumatology, Agia Sofia Children's Hospital, Athens, GRC
Epidemiology and Public Health, National and Kapodistrian University of Athens, Athens, GRC
Orthopaedics and Traumatology, Livadeia General Hospital, Livadeia, GRC
Orthopaedics and Traumatology, Agia Sofia Children's Hospital, Athens, GRC
Orthopaedics and Traumatology, Agia Sofia Children's Hospital, Athens, GRC
Orthopaedics and Traumatology, Agia Sofia Children's Hospital, Athens, GRC
Human subjects: Consent was obtained or waived by all participants in this study. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.
Tirta M, Ampelas D, Tsintavis P, et al. (August 05, 2022) Salmonella Septic Hip Arthritis in Immunocompetent Children: Three Case Reports and Literature Review. Cureus 14(8): e27701. doi:10.7759/cureus.27701
Peer review began: June 29, 2022 Peer review concluded: August 01, 2022 Published: August 05, 2022
© Copyright 2022 Tirta et al. This is an open access article distributed under the terms of the Creative Commons Attribution License CC-BY 4.0., which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
The yellow arrow shows the subluxation of the left femoral head. Fluoroscopy-assisted closed reduction was performed and maintained with a hip spica cast.
The yellow arrow shows that the epiphysis of the femoral head had vanished due to the ongoing osteonecrosis.
The yellow arrow the remodeling of the femoral head after two years. The patient has no symptoms and is able to bear weight.
Range of inflammatory markers' normal values for our hospital's lab: WBC - 3.6-9.5x103/μL, CRP - 1-10mg/L, ESR - 3-13mm/hr
A, ampicillin; Am, Amoxycillin; Amk, amikacin; AmoCl, Amoxicillin clavulanic acid; C, chloramphenicol; Cef, cefixime; Cro, ceftriaxone; Cz, Ceftazidime; Cfo, Cefotaxime; Ci, Clindamycin; Cip, ciprofloxacin; Cipi, intermediate susceptibility to ciprofloxacin; Co, Cotrimaxazole; Cu, Cefuraxime; Ge, Gentamycin; Me, Meropenem; Na, nalidixic acid; Ofl, ofloxacin; Su, sulphamethoxazole; Te, Tetracycline; Tm, trimethoprim; IV, intravenous; PO, oral; yr, years; mo, months; wks, weeks.
Scholarly Impact Quotient™ (SIQ™) is our unique post-publication peer review rating process. Learn more here.
This link will take you to a third party website that is not affiliated with Cureus, Inc. Please note that Cureus is not responsible for any content or activities contained within our partner or affiliate websites.
Scholarly Impact Quotient™ (SIQ™) is our unique post-publication peer review rating process. SIQ™ assesses article importance and quality by embracing the collective intelligence of the Cureus community-at-large. All registered users are invited to contribute to the SIQ™ of any published article. (Authors cannot rate their own articles.)
High ratings should be reserved for work that is truly groundbreaking in its respective field. Anything above 5 should be considered above average. While all registered Cureus users can rate any published article, the opinion of domain experts is weighted appreciably more than that of non-specialists. An article’s SIQ™ will appear alongside the article after being rated twice and is recalculated with each additional rating.
Visit our SIQ™ page to find out more.
Scholarly Impact Quotient™ (SIQ™) is our unique post-publication peer review rating process. SIQ™ assesses article importance and quality by embracing the collective intelligence of the Cureus community-at-large. All registered users are invited to contribute to the SIQ™ of any published article. (Authors cannot rate their own articles.)
Already have an account? Sign in.
Please note that by doing so you agree to be added to our monthly email newsletter distribution list.
By joining Cureus, you agree to our Privacy Policy and Terms of Use.